Resultats de la cerca - Giné, Eva

Development of Survival Responsiveness to Brain-Derived Neurotrophic Factor, Neurotrophin 3 and Neurotrophin 4/5, But Not to Nerve Growth Factor, in Cultured Motoneurons from Chick... per Becker, Elena, Soler, Rosa M., Yuste, Víctor J., Giné, Eva, Sanz-Rodríguez, César, Egea, Joaquim, Martín-Zanca, Dionisio, Comella, Joan X.

Obtenir text complet Obtenir text complet Obtenir text complet

Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia per Mozas, Pablo, Rivas-Delgado, Alfredo, Baumann, Tycho, Villamor, Neus, Ortiz-Maldonado, Valentín, Aymerich, Marta, Costa, Dolors, Navarro, Alba, Giné, Eva, López-Guillermo, Armando, Montserrat, Emili, Delgado, Julio

Obtenir text complet Obtenir text complet Obtenir text complet

Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy per Rovira, Jordina, Valera, Alexandra, Colomo, Lluis, Setoain, Xavier, Rodríguez, Sonia, Martínez-Trillos, Alejandra, Giné, Eva, Dlouhy, Ivan, Magnano, Laura, Gaya, Anna, Martínez, Daniel, Martínez, Antonio, Campo, Elías, López-Guillermo, Armando

Obtenir text complet Obtenir text complet Obtenir text complet

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinic... per Giné, Eva, Martinez, Antoni, Villamor, Neus, López-Guillermo, Armando, Camos, Mireia, Martinez, Daniel, Esteve, Jordi, Calvo, Xavier, Muntañola, Ana, Abrisqueta, Pau, Rozman, Maria, Rozman, Ciril, Bosch, Francesc, Campo, Elias, Montserrat, Emili

Obtenir text complet Obtenir text complet Obtenir text complet

Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience per Mozas, Pablo, Nadeu, Ferran, Rivas-Delgado, Alfredo, Rivero, Andrea, Garrote, Marta, Balagué, Olga, González-Farré, Blanca, Veloza, Luis, Baumann, Tycho, Giné, Eva, Delgado, Julio, Villamor, Neus, Campo, Elías, Magnano, Laura, López-Guillermo, Armando

Obtenir text complet Obtenir text complet Obtenir text complet

The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational sta... per Vidal-Crespo, Anna, Rodriguez, Vanina, Matas-Cespedes, Alba, Lee, Eriong, Rivas-Delgado, Alfredo, Giné, Eva, Navarro, Alba, Beà, Sílvia, Campo, Elias, López-Guillermo, Armando, Lopez-Guerra, Monica, Roué, Gaël, Colomer, Dolors, Pérez-Galán, Patricia

Obtenir text complet Obtenir text complet Obtenir text complet

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin? per Magnano, Laura, Navarro, Alba, López-Guerra, Mónica, Clot, Guillem, Beà, Sílvia, Bastidas, Gabriela, Costa, Dolors, Rivero, Andrea, Garrote, Marta, Giné, Eva, Rozman, María, Aymerich, Marta, Colomer, Dolors, López-Guillermo, Armando, Campo, Elías, Villamor, Neus, Matutes, Estella

Obtenir text complet Obtenir text complet Obtenir text complet

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact per Mozas, Pablo, Piñeyroa, Juan A., Nadeu, Ferran, Magnano, Laura, Rivero, Andrea, Rivas-Delgado, Alfredo, Bataller, Alex, Fabregat, Aleix, Giné, Eva, Baumann, Tycho, Villamor, Neus, Aróstegui, Juan Ignacio, Aymerich, Marta, López-Guillermo, Armando, Campo, Elías, Delgado, Julio

Obtenir text complet Obtenir text complet Obtenir text complet

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma per Rivas-Delgado, Alfredo, Nadeu, Ferran, Andrade-Campos, Marcio, López, Cristina, Enjuanes, Anna, Mozas, Pablo, Frigola, Gerard, Colomo, Luis, Sanchez-Gonzalez, Blanca, Villamor, Neus, Beà, Sílvia, Campo, Elías, Salar, Antonio, Giné, Eva, López-Guillermo, Armando, Bellosillo, Beatriz

Obtenir text complet Obtenir text complet Obtenir text complet

Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance per Garcia-Vidal, Carolina, Cardozo-Espinola, Celia, Puerta-Alcalde, Pedro, Marco, Francesc, Tellez, Adrian, Agüero, Daiana, Romero-Santana, Francisco, Díaz-Beyá, Marina, Giné, Eva, Morata, Laura, Rodríguez-Núñez, Olga, Martinez, Jose Antonio, Mensa, Josep, Esteve, Jordi, Soriano, Alex

Obtenir text complet Obtenir text complet Obtenir text complet

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma per Dang, Nam H., Ogura, Michinori, Castaigne, Sylvie, Fayad, Luis E., Jerkeman, Mats, Radford, John, Pezzutto, Antonio, Bondarenko, Igor, Stewart, Douglas A., Shnaidman, Michael, Sullivan, Sharon, Vandendries, Erik, Tobinai, Kensei, Ramchandren, Radhakrishnan, Hamlin, Paul A., Giné, Eva, Ando, Kiyoshi

Obtenir text complet Obtenir text complet Obtenir text complet

The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy per Santacruz, Rodrigo, Villamor, Neus, Aymerich, Marta, Martínez-Trillos, Alejandra, López, Cristina, Navarro, Alba, Rozman, María, Beà, Sílvia, Royo, Cristina, Cazorla, Maite, Colomer, Dolors, Giné, Eva, Pinyol, Magda, Puente, Xose S., López-Otín, Carlos, Campo, Elías, López-Guillermo, Armando, Delgado, Julio

Obtenir text complet Obtenir text complet Obtenir text complet

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry per Tilch, Marie-Kristin, Visco, Carlo, Kinda, Sandra, Hermine, Olivier, Kohn, Milena, Besson, Caroline, Lamure, Sylvain, Duléry, Rémy, Ragaini, Simone, Eyre, Toby A., Van Meerten, Tom, Ohler, Anke, Eckerle, Steffen, Dreyling, Martin, Hess, Georg, Giné, Eva, Gomes da Silva, Maria

Obtenir text complet Obtenir text complet Obtenir text complet

Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma per Fuster, Carla, Martín-Garcia, David, Balagué, Olga, Navarro, Alba, Nadeu, Ferran, Costa, Dolors, Prieto, Miriam, Salaverria, Itziar, Espinet, Blanca, Rivas-Delgado, Alfredo, Terol, Maria José, Giné, Eva, Forcada, Pilar, Ashton-Key, Margaret, Puente, Xose S., Swerdlow, Steven H., Beà, Sílvia, Campo, Elias

Obtenir text complet Obtenir text complet Obtenir text complet

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a S... per Rivero, Andrea, Mozas, Pablo, Jiménez, Laura, López-Guerra, Mónica, Colomer, Dolors, Bataller, Alex, Correa, Juan, Rivas-Delgado, Alfredo, Bastidas, Gabriela, Baumann, Tycho, Martínez-Trillos, Alejandra, Delgado, Julio, Giné, Eva, Campo, Elías, López-Guillermo, Armando, Villamor, Neus, Magnano, Laura, Matutes, Estella

Obtenir text complet Obtenir text complet Obtenir text complet

SOX11, CD70, and T(reg) cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma per Balsas, Patricia, Veloza, Luis, Clot, Guillem, Sureda-Gómez, Marta, Rodríguez, Marta-Leonor, Masaoutis, Christos, Frigola, Gerard, Navarro, Alba, Beà, Silvia, Nadeu, Ferran, Giné, Eva, López-Guillermo, Armando, Martínez, Antonio, Ribera-Cortada, Inmaculada, Engel, Pablo, Quintanilla-Martínez, Leticia, Klapper, Wolfram, Campo, Elias, Amador, Virginia

Obtenir text complet Obtenir text complet Obtenir text complet

Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evalua... per Fayad, Luis, Offner, Fritz, Smith, Mitchell R., Verhoef, Gregor, Johnson, Peter, Kaufman, Jonathan L., Rohatiner, Ama, Advani, Anjali, Foran, James, Hess, Georg, Coiffier, Bertrand, Czuczman, Myron, Giné, Eva, Durrant, Simon, Kneissl, Michelle, Luu, Kenneth T., Hua, Steven Y., Boni, Joseph, Vandendries, Erik, Dang, Nam H.

Obtenir text complet Obtenir text complet Obtenir text complet

The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia per Matas-Céspedes, Alba, Vidal-Crespo, Anna, Rodriguez, Vanina, Villamor, Neus, Delgado, Julio, Giné, Eva, Roca-Ho, Heleia, Menéndez, Pablo, Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Roué, Gaël, Wiestner, Adrian, Parren, Paul W.H.I., Doshi, Parul, van Bueren, Jeroen Lammerts, Pérez-Galán, Patricia

Obtenir text complet Obtenir text complet Obtenir text complet

Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens per Vidal-Crespo, Anna, Matas-Céspedes, Alba, Rodriguez, Vanina, Rossi, Cédric, Valero, Juan G., Serrat, Neus, Sanjuan-Pla, Alejandra, Menéndez, Pablo, Roué, Gaël, López-Guillermo, Armando, Giné, Eva, Campo, Elías, Colomer, Dolors, Bezombes, Christine, van Bueren, Jeroen Lammerts, Chiu, Christopher, Doshi, Parul, Pérez-Galán, Patricia

Obtenir text complet Obtenir text complet Obtenir text complet

A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma per Demajo, Santiago, Albero, Robert, Clot, Guillem, Castellano, Giancarlo, Navarro, Alba, Capdevila, Cristina, Enjuanes, Anna, Nadeu, Ferran, Giné, Eva, Pinyol, Magda, Jaffe, Elaine S., Ott, German, Staudt, Louis M., Rosenwald, Andreas, Scott, David W., Rimsza, Lisa M., López-Guillermo, Armando, Beà, Sílvia, Campo, Elias, Jares, Pedro

Obtenir text complet Obtenir text complet Obtenir text complet